135 related articles for article (PubMed ID: 38168561)
1. Blocking tumor-platelet crosstalk to prevent tumor metastasis via reprograming glycolysis using biomimetic membrane-hybridized liposomes.
Zhu J; Wang R; Yang C; Shao X; Zhang Y; Hou J; Gao Y; Ou A; Chen M; Huang Y
J Control Release; 2024 Feb; 366():328-341. PubMed ID: 38168561
[TBL] [Abstract][Full Text] [Related]
2. Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery.
Long L; Xiong W; Lin F; Hou J; Chen G; Peng T; He Y; Wang R; Xu Q; Huang Y
J Exp Clin Cancer Res; 2023 May; 42(1):117. PubMed ID: 37161591
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming by dual-targeting biomimetic nanoparticles for enhanced tumor chemo-immunotherapy.
Zang S; Huang K; Li J; Ren K; Li T; He X; Tao Y; He J; Dong Z; Li M; He Q
Acta Biomater; 2022 Aug; 148():181-193. PubMed ID: 35649505
[TBL] [Abstract][Full Text] [Related]
4. Blockade of Platelets Using Tumor-Specific NO-Releasing Nanoparticles Prevents Tumor Metastasis and Reverses Tumor Immunosuppression.
Xu Y; Liu J; Liu Z; Ren H; Yong J; Li W; Wang H; Yang Z; Wang Y; Chen G; Li X
ACS Nano; 2020 Aug; 14(8):9780-9795. PubMed ID: 32806062
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
[TBL] [Abstract][Full Text] [Related]
6. Targeted Inhibition of Tumor Inflammation and Tumor-Platelet Crosstalk by Nanoparticle-Mediated Drug Delivery Mitigates Cancer Metastasis.
Li S; Li L; Lin X; Chen C; Luo C; Huang Y
ACS Nano; 2022 Jan; 16(1):50-67. PubMed ID: 34873906
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of platelet function using liposomal nanoparticles blocks tumor metastasis.
Zhang Y; Wei J; Liu S; Wang J; Han X; Qin H; Lang J; Cheng K; Li Y; Qi Y; Anderson GJ; Sukumar S; Li S; Nie G
Theranostics; 2017; 7(5):1062-1071. PubMed ID: 28435448
[TBL] [Abstract][Full Text] [Related]
8. Targeting lactate metabolism and immune interaction in breast tumor via protease-triggered delivery.
Zhao P; Wang S; Jiang J; Gao Y; Wang Y; Zhao Y; Zhang J; Zhang M; Huang Y
J Control Release; 2023 Jun; 358():706-717. PubMed ID: 37207796
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions.
Wenzel J; Zeisig R; Fichtner I
Clin Exp Metastasis; 2010; 27(1):25-34. PubMed ID: 19916050
[TBL] [Abstract][Full Text] [Related]
10. Platelet Metabolic Profiling Reveals Glycolytic and 1-Carbon Metabolites Are Essential for GP VI-Stimulated Human Platelets-Brief Report.
Ghatge M; Flora GD; Nayak MK; Chauhan AK
Arterioscler Thromb Vasc Biol; 2024 Feb; 44(2):409-416. PubMed ID: 37942614
[TBL] [Abstract][Full Text] [Related]
11. Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis.
Zhao X; Zhu Y; Hu J; Jiang L; Li L; Jia S; Zen K
Sci Rep; 2018 Sep; 8(1):14517. PubMed ID: 30266938
[TBL] [Abstract][Full Text] [Related]
12. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
[TBL] [Abstract][Full Text] [Related]
13. Biomimetic Decoy Inhibits Tumor Growth and Lung Metastasis by Reversing the Drawbacks of Sonodynamic Therapy.
Zhao H; Zhao B; Li L; Ding K; Xiao H; Zheng C; Sun L; Zhang Z; Wang L
Adv Healthc Mater; 2020 Jan; 9(1):e1901335. PubMed ID: 31762228
[TBL] [Abstract][Full Text] [Related]
14. Platelet-biomimetic nanoparticles for in vivo targeted photodynamic therapy of breast cancer.
Song Y; Tan X; Gao Y
J Biomater Sci Polym Ed; 2022 Aug; 33(11):1383-1397. PubMed ID: 35321618
[TBL] [Abstract][Full Text] [Related]
15. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism.
Zhou Q; Yin Y; Yu M; Gao D; Sun J; Yang Z; Weng J; Chen W; Atyah M; Shen Y; Ye Q; Li CW; Hung MC; Dong Q; Zhou C; Ren N
Redox Biol; 2022 Oct; 56():102458. PubMed ID: 36116159
[TBL] [Abstract][Full Text] [Related]
16. Glucose metabolism and metabolic flexibility in blood platelets.
Aibibula M; Naseem KM; Sturmey RG
J Thromb Haemost; 2018 Nov; 16(11):2300-2314. PubMed ID: 30151891
[TBL] [Abstract][Full Text] [Related]
17. Pirfenidone inhibits TGF-β1-induced metabolic reprogramming during epithelial-mesenchymal transition in non-small cell lung cancer.
Zhang S; Wang Y; Luo D; Cheng Z; Zeng Q; Wang G; Chen M; Zhang S; Luo P
J Cell Mol Med; 2024 Feb; 28(3):e18059. PubMed ID: 38140828
[TBL] [Abstract][Full Text] [Related]
18. Targeting self-assembly peptide for inhibiting breast tumor progression and metastasis.
Luo S; Feng J; Xiao L; Guo L; Deng L; Du Z; Xue Y; Song X; Sun X; Zhang Z; Fu Y; Gong T
Biomaterials; 2020 Aug; 249():120055. PubMed ID: 32315863
[TBL] [Abstract][Full Text] [Related]
19. Platelet adherence to cancer cells promotes escape from innate immune surveillance in cancer metastasis.
Okazaki M; Yamaguchi T; Tajima H; Fushida S; Ohta T
Int J Oncol; 2020 Oct; 57(4):980-988. PubMed ID: 32945350
[TBL] [Abstract][Full Text] [Related]
20. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge".
Zhao W; Li T; Long Y; Guo R; Sheng Q; Lu Z; Li M; Li J; Zang S; Zhang Z; He Q
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25701-25714. PubMed ID: 34041901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
